| Amyloidosis studied in …STUDIED_INderived47 of 47show fewer |
|---|
| → studied in | NCT07172243recruiting BE.Amycon Biobank & Data Registry UZ Leuven · condition mapped ONTOLOGY_EXACT · 47 trials mapped (11 active) | — | — | Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05283993recruiting A Cohort Study of Plasma Cell Disorders (PCDs) in PKUFH · condition mapped ONTOLOGY_EXACT · 47 trials mapped (11 active) | — | — | Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05145816Phase 1/Phase 2 · recruiting Phase 1/2a Study of Belantamab Mafodotin in Relapsed or Refractory AL Amyloidosis · condition mapped ONTOLOGY_EXACT · 47 trials mapped (11 active) | — | — | Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07285044Phase 2 · recruiting The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas · condition mapped ONTOLOGY_EXACT · 47 trials mapped (11 active) | — | — | Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07224672Phase 2 · recruiting A Study to Evaluate the Efficacy and Safety of Belantamab Mafodotin in Combination With Cyclophosphamide, Bortezomib, and Dexamethasone in Adult Participants With Newly Diagnosed Amyloid Light Chain (AL) Amyloidosis · condition mapped ONTOLOGY_EXACT · 47 trials mapped (11 active) | — | — | Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07081646Phase 1/Phase 2 · recruiting A Phase 1b/2 Study of CAR T Cell Therapy Targeting CD19 and BCMA in Participants With Relapsed or Refractory AL Amyloidosis. · condition mapped ONTOLOGY_EXACT · 47 trials mapped (11 active) | — | — | Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03431896completed Monitoring of Early Disease Progression in Hereditary Transthyretin Amyloidosis · condition mapped ONTOLOGY_EXACT · 47 trials mapped (11 active) | — | — | Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03123029available Expanded Access to Venetoclax · condition mapped ONTOLOGY_EXACT · 47 trials mapped (11 active) | — | — | Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06573723recruiting Institutional Registry of Rare Diseases · condition mapped ONTOLOGY_EXACT · 47 trials mapped (11 active) | — | — | Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04991103Phase 2 · recruiting Minimal Residual Disease Response-adapted Deferral of Transplant in Dysproteinemia (MILESTONE) · condition mapped ONTOLOGY_EXACT · 47 trials mapped (11 active) | — | — | Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05556928recruiting Cancer and Aging Resilience Evaluation in Older Adults With Hematologic Malignancies: The CARE-Heme Registry · condition mapped ONTOLOGY_EXACT · 47 trials mapped (11 active) | — | — | Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03717844recruiting Registry for Adults With Plasma Cell Disorders (PCD's) · condition mapped ONTOLOGY_EXACT · 47 trials mapped (11 active) | — | — | Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02909036Phase 1 · active not recruiting Study of Captisol Enabled Melphalan and Pharmacokinetics for Patients With Multiple Myeloma or Light Chain Amyloidosis That Are Receiving an Autologous Transplant. · condition mapped ONTOLOGY_EXACT · 47 trials mapped (11 active) | — | — | Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01864018Phase 1/Phase 2 · completed Ixazomib With Cyclophosphamide and Dexamethasone in Patients With Previously Untreated Symptomatic Multiple Myeloma or Light Chain Amyloidosis · condition mapped ONTOLOGY_EXACT · 47 trials mapped (11 active) | — | — | Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02924272Phase 2 · completed Ixazomib Rollover Study · condition mapped ONTOLOGY_EXACT · 47 trials mapped (11 active) | — | — | Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06539169unknown FLOWER: Following Longitudinal Outcomes With Epidemiology for Rare Diseases · condition mapped ONTOLOGY_EXACT · 47 trials mapped (11 active) | — | — | Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05260203NA · completed MargheRITA (Remote Intelligence for Therapeutic Adherence) · condition mapped ONTOLOGY_EXACT · 47 trials mapped (11 active) | — | — | Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05199337Phase 1/Phase 2 · completed Phase 1/2 Study of ZN-d5 for the Treatment of Relapsed or Refractory Light Chain (AL) Amyloidosis · condition mapped ONTOLOGY_EXACT · 47 trials mapped (11 active) | — | — | Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05635266unknown Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Initiatives · condition mapped ONTOLOGY_EXACT · 47 trials mapped (11 active) | — | — | Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04942067Phase 1/Phase 2 · unknown APG-2575 in Combination With Novel Therapeutic Regimens in Subjects With Relapsed or Refractory Multiple Myeloma · condition mapped ONTOLOGY_EXACT · 47 trials mapped (11 active) | — | — | Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05174338unknown Cardiac Amyloidosis Registry Study · condition mapped ONTOLOGY_EXACT · 47 trials mapped (11 active) | — | — | Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03959358Phase 2 · completed A Study to Desensitize Allergic Reactions to Treatments for Blood Disorders · condition mapped ONTOLOGY_EXACT · 47 trials mapped (11 active) | — | — | Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02158052NA · completed Combined Bone Marrow and Renal Transplantation for Hematologic Disorders With End Stage Renal Disease · condition mapped ONTOLOGY_EXACT · 47 trials mapped (11 active) | — | — | Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04984330early Phase 1 · withdrawn Selinexor for Treatment of Light Chain Amyloidosis With Relapsed/Refractory Disease · condition mapped ONTOLOGY_EXACT · 47 trials mapped (11 active) | — | — | Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02589860withdrawn Analysis of Oral Mucositis in Patient's Undergoing Melphalan Conditioning and Autologous Stem Cell Transplant · condition mapped ONTOLOGY_EXACT · 47 trials mapped (11 active) | — | — | Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03886155completed Cardiac Amyloidosis Screening at Trigger Finger Release · condition mapped ONTOLOGY_EXACT · 47 trials mapped (11 active) | — | — | Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03923920completed Screening for Systemic Amyloidosis Via the Ligamentum Flavum · condition mapped ONTOLOGY_EXACT · 47 trials mapped (11 active) | — | — | Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02716103completed Assessment of Minimal Residual Disease (MRD) After Antineoplastic Treatment in Patients With AL Amyloidosis · condition mapped ONTOLOGY_EXACT · 47 trials mapped (11 active) | — | — | Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00981708Phase 1/Phase 2 · completed Lenalidomide, Dexamethasone and Cyclophosphamide in Amyloidosis (AL) · condition mapped ONTOLOGY_EXACT · 47 trials mapped (11 active) | — | — | Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02545907Phase 1/Phase 2 · completed A Dose Escalation Study of Carfilzomib Taken With Thalidomide and Dexamethasone in Relapsed AL Amyloidosis · condition mapped ONTOLOGY_EXACT · 47 trials mapped (11 active) | — | — | Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01083316Phase 2 · completed Bortezomib and Dexamethasone Followed by High-Dose Melphalan and Stem Cell Transplantation for Primary (AL) Amyloidosis · condition mapped ONTOLOGY_EXACT · 47 trials mapped (11 active) | — | — | Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02555969completed Minimal Residual Disease as a Possible Predictive Factor for Relapse in Patients With AL Amyloidosis · condition mapped ONTOLOGY_EXACT · 47 trials mapped (11 active) | — | — | Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01383759NA · completed Bortezomib/Dexamethasone (BD), Followed By Autologous Stem Cell Transplantation and Maintenance Bortezomib/Dexamethasone For the Initial Treatment of Monoclonal Immunoglobulin Deposition Disease (MIDD) Associated With Multiple Myeloma and AL Amyloidosis · condition mapped ONTOLOGY_EXACT · 47 trials mapped (11 active) | — | — | Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02603172Phase 1 · terminated A Safety Study of GSK3039294 in Healthy Volunteers and Patients With Systemic Amyloidosis · condition mapped ONTOLOGY_EXACT · 47 trials mapped (11 active) | — | — | Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02574676completed Quality of Life (QOL) Registry for Patients With AL Amyloidosis · condition mapped ONTOLOGY_EXACT · 47 trials mapped (11 active) | — | — | Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01777243Phase 1 · completed A Study to Evaluate the Safety of GSK2398852 When Co-administered With GSK2315698 in Patients With Systemic Amyloidosis · condition mapped ONTOLOGY_EXACT · 47 trials mapped (11 active) | — | — | Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00952237Phase 1 · completed Immune Mobilization of Autologous Peripheral Blood Stem Cells Using Interleukin-2 and GM-CSF · condition mapped PROBABILISTIC · 47 trials mapped (11 active) | — | — | Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02791373Phase 2 · completed Vinorelbine and Gemcitabine in Myeloma · condition mapped ONTOLOGY_EXACT · 47 trials mapped (11 active) | — | — | Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01677286Phase 2 · completed Safety and Effect of Doxycycline in Patients With Amyloidosis · condition mapped ONTOLOGY_EXACT · 47 trials mapped (11 active) | — | — | Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01406314Phase 1 · completed SAP Depleter Dose Assessment Study in Patients · condition mapped ONTOLOGY_EXACT · 47 trials mapped (11 active) | — | — | Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00890552NA · completed A Pilot Study of Lenalidomide, Melphalan and Dexamethasone in AL Amyloidosis · condition mapped ONTOLOGY_EXACT · 47 trials mapped (11 active) | — | — | Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02953808Phase 1 · completed Phase 1 Study of GSK2315698 in Healthy Japanese Subjects · condition mapped ONTOLOGY_EXACT · 47 trials mapped (11 active) | — | — | Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01135849completed B-Receptor Signaling in Cardiomyopathy · condition mapped ONTOLOGY_EXACT · 47 trials mapped (11 active) | — | — | Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00919139completed S0309, Repository: Blood/Bone Marrow From Pts. With Myeloma, WM, Amyloidosis, or MGUS. · condition mapped ONTOLOGY_EXACT · 47 trials mapped (11 active) | — | — | Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01998503Phase 3 · completed Bortezomib and Dexamethasone Followed by ASCT Compared With ASCT Alone in Treating Patients With AL Amyloidosis · condition mapped ONTOLOGY_EXACT · 47 trials mapped (11 active) | — | — | Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00621400Phase 1/Phase 2 · completed Lenalidomide in Combination With Melphalan and Dexamethasone in Newly-diagnosed Light-chain (AL)-Amyloidosis · condition mapped ONTOLOGY_EXACT · 47 trials mapped (11 active) | — | — | Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00017680Phase 2 · completed Study of High-Dose Melphalan and Autologous Stem Cell Transplantation in Patients With Primary Light Chain Amyloidosis · condition mapped ONTOLOGY_EXACT · 47 trials mapped (11 active) | — | — | Amyloidosis | 1 | Observed | clinicaltrials | graph → |